Michael A. Maldonado, MD

Clinical Development Lead
Bristol Myers Squibb
Princeton, New Jersey, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• LB1531A - Administration of abatacept, reduces mortality in hospitalized patients with COVID pneumonia. Results of a randomized controlled trial.

  Friday, October 21, 2022
  2:15 PM – 2:25 PM US ET